In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
Lower baseline kidney function and proton pump inhibitor use increased the risk for acute kidney injury associated with immune checkpoint inhibitor therapy.
Patients who survive the first 30 days of COVID-19 are more likely to have acute kidney injury and chronic kidney disease compared with those who do not contract the disease.
Daprodustat is as effective as erythropoiesis-stimulating agents in treating anemia in patients with dialysis-dependent and nondialysis-dependent chronic kidney disease.
Offspring exposed to hypertensive disorders of pregnancy in gestation and those with maternal hypertension should be considered an elevated risk group, investigators concluded.
Long-term aspirin use by patients with nondialysis chronic kidney disease is associated with a lower risk for adverse kidney outcomes and death, a study found.